Evotec Names Dr Tim Tasker Executive Vice President Clinical Development and Member of the Executive Committee

07-Jul-2005

Evotec AG announced the appointment of Dr Tim Tasker as Executive Vice President Clinical Development and a member of its Executive Committee. He will lead Evotec's clinical development activities. Evotec has created this position following the acquisition of Evotec Neurosciences and the implementation of its strategy to increasingly focus on internal drug development with a focus on CNS diseases.

Dr Tasker, 52, will join Evotec with effect from 11 July 2005. He is a MD by training and brings more than 23 years of global clinical development and business expertise at Beecham, SmithKline Beecham (SB) and now GlaxoSmithKline (GSK), one of the leading pharmaceutical companies worldwide, to the Company. Most recently, Dr Tasker was Vice President Global Clinical Units, Clinical Pharmacology and Discovery Medicine and Member of the GSK Global Safety Board.

During his career Dr Tasker has gained deep drug development expertise at all stages. He has a strong background in clinical pharmacology and a particular ability in early development to proof-of-concept in man (Phase I, Phase IIa and Clinical Pharmacology Programmes). Through most of the 90s he headed SB's clinical pharmacology across Europe, where he was responsible for the design and implementation of early development plans for 50% of SB's portfolio. In addition, Dr Tasker was a key member of the Neurosciences Therapeutic Area Team. In this role he reviewed all in-licensed compounds and contributed to the selection of new molecules, their prioritisation and development planning together with the strategy for commercialisation of every neurosciences compound in SB's portfolio. In his career he has overseen more than 40 different compounds of many different pharmacologies moving from discovery into early development.

Dr Tasker has a Physiological Sciences first Class Honours Degree (BA Hons) from University of Oxford and a Medical Degree (MBBS) from London University, England. He is a Fellow of the Royal College of Physicians of the UK, and a Fellow and member of the Board of the Faculty of Pharmaceutical Medicine of the Royal College of Physicians.

https://www.bionity.com/en/news/47495/evotec-names-dr-tim-tasker-executive-vice-president-clinical-development-and-member-of-the-executive-committee.html